World Health Organization. WHO Global Surveillance and Monitoring System for substandard and falsified medical products. Geneva: World Health Organization, 2017. http://apps.who.int/medicinedocs/en/m/abstract/Js23373en/ (accessed Oct 16, 2019).
World Health Organization. A study on the public health and socioeconomic impact of substandard and falsified medical products. Geneva: World Health Organization, 2017. http://apps.who.int/medicinedocs/en/m/abstract/Js23372en/ (accessed Oct 16, 2019).
Ozawa S, Evans DR, Bessias S, et al. Prevalence and estimated economic burden of substandard and falsified medicines in low- and middle-income countries: a systematic review and meta-analysis. JAMA Netw Open 2018; 1: e181662.
World Health Organization. Survey of the quality of medicines identified by the United Nations Commission on Life Saving Commodities for women and children. https://extranet.who.int/prequal/sites/default/files/documents/UNCoLSC_2015.pdf (accessed Oct 16, 2019).
Peyraud N, Rafael F, Parker LA, et al. An epidemic of dystonic reactions in central Africa. Lancet Glob Health 2017; 5: e137–38.
Godlee F. Why aren't medical devices regulated like drugs? BMJ 2018; 363: k5032.
Antignac M, Diop BI, Macquart de Terline D, et al. Fighting fake medicines: first quality evaluation of cardiac drugs in Africa. Int J Cardiol 2017; 243: 523–28.
World Health Organization. Tanzania is first African country to reach an important milestone in the regulation of medicines. https://www.afro.who.int/news/tanzania-first-african-country-reach-important-milestone-regulation-medicines (accessed Oct 16, 2019).
